ICPT — Intercept Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $793.52m
- $713.07m
- $285.71m
U.S. RESEARCH ROUNDUP-Dice Therapeutics, Mongodb, Valvoline
U.S. STOCKS ON THE MOVE-Graphite Bio, Leggett & Platt, Nauticus Robotics
U.S. STOCKS ON THE MOVE-Nike, Nikola, Trupanion
U.S. STOCKS ON THE MOVE-CarMax, Wayfair, Starbucks
Intercept Pharma gains on restructuring plan, job cuts
Refinitiv Newscasts - U.S. Morning Call: Stock futures fall as investors play the terminal-rates guessing game
Brief: Intercept Receives Complete Response Letter From FDA For Obeticholic Acid As A Treatment For Pre-Cirrhotic Fibrosis Due To Nash
Brief: Intercept To Reduce Workforce By About One Third
Brief: Intercept Pharmaceuticals Expects To Incur About $16 Million In Restructuring Costs
Brief: Intercept Presents New Data Showing Significant Impact Of Oca-Bezafibrate Combination On Normalization Of Multiple Biomarkers Of Pbc-Induced Liver Damage
US FDA declines to approve Intercept's fatty liver disease drug (updated)
US FDA declines to approve Intercept's fatty liver disease drug
What to Watch in the Day Ahead - Thursday, June 22
What to Watch in the Week Ahead and on Tuesday, June 20
U.S. STOCKS ON THE MOVE-Adobe, Nikola, copper miners
U.S. STOCKS ON THE MOVE-Premier, Canadian Solar, Jabil
U.S. STOCKS ON THE MOVE-Premier, Canadian Solar, Jabil
RBC trims PT on Intercept as NASH drug development 'likely to wind down', shares fall
U.S. STOCKS ON THE MOVE-Biogen, Phoenix Motor, Mastercard